S N Madhusudana. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisDeveloping CountriesDose-Response Relationship, ImmunologicHumansIndiaInjections, IntradermalRabies/economicsRabies/prevention & controlRabies Vaccines/administration & dosageRabies Vaccines/economicsRabies Vaccines/therapeutic use
Substances: See more » Rabies Vaccines
Year: 2003 PMID: 12804834 DOI: 10.1016/s0264-410x(03)00263-9
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641